CompoAtlas

Guipiwan

Natural health product licensed in Canada

Licence holder
Pharma Herb Inc.
NPN or DIN-HM
80030645
Status
Active licence
Licence date
21 March 2012
Revision date
Not provided
Form
Pilule
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Codonopsis pilosula

Source : Racine séchée

80 mgNot calculated
Atractylodes macrocephala

Source : Rhizome

160 mgNot calculated
Saussurea costus

Source : Racine séchée

40 mgNot calculated
Polygala tenuifolia

Source : Racine séchée

160 mgNot calculated
Dimocarpus longan

Source : Chair (fruit)

160 mgNot calculated

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
AdultesNot specified8 Pilule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Traditional Chinese Medicine used for deficiency syndrome of both the heart and the spleen marked by shortness of breath, cardiac palpitation, insomnia, dream-disturbed sleep, dizziness, lassitude, anorexia, excessive menstrual discharge or hemorrhoid.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80030645

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line